As of January 23, 2025, Imunon (IMNN) has a market cap of $12.909 million USD. According to our data, Imunon is ranked No.8775 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $12.91 M |
-6.29%
|
Dec 31, 2024 | $13.78 M |
39.71%
|
Dec 29, 2023 | $9.86 M |
-49.63%
|
Dec 30, 2022 | $19.58 M |
-83.33%
|
Dec 31, 2021 | $0.12 B |
-23.94%
|
Dec 31, 2020 | $0.15 B |
-58.48%
|
Dec 31, 2019 | $0.37 B |
21.28%
|
Dec 31, 2018 | $0.31 B |
-47.39%
|
Dec 29, 2017 | $0.58 B |
-36.19%
|
Dec 30, 2016 | $0.91 B |
-84.38%
|
Dec 31, 2015 | $5.85 B |
-17.60%
|
Dec 31, 2014 | $7.10 B |
-40.10%
|
Dec 31, 2013 | $11.85 B |
-89.46%
|
Dec 31, 2012 | $112.34 B |
381.76%
|
Dec 30, 2011 | $23.32 B |
-17.07%
|
Dec 31, 2010 | $28.12 B |
-37.31%
|
Dec 31, 2009 | $44.85 B |
48.64%
|
Dec 31, 2008 | $30.18 B |
-25.93%
|
Dec 31, 2007 | $40.74 B |
56.32%
|
Dec 29, 2006 | $26.06 B |
-53.09%
|
Dec 30, 2005 | $55.55 B |
-52.63%
|
Dec 31, 2004 | $117.28 B |
-56.49%
|
Dec 31, 2003 | $269.54 B |
204.65%
|
Dec 31, 2002 | $88.47 B |
-34.85%
|
Dec 31, 2001 | $135.80 B |
-34.00%
|
Dec 29, 2000 | $205.75 B |
-65.96%
|
Dec 31, 1999 | $604.40 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
BioNTech
BNTX
|
$27.61 B |
0.000 M
|
Germany
|
Novavax
NVAX
|
$1.41 B |
-0.000 M
|
USA
|
Inovio Pharmaceuticals
INO
|
$81.23 M |
0.000 M
|
USA
|
Curevac
CVAC
|
$0.89 B |
0.000 M
|
Germany
|
Arcturus Therapeutics
ARCT
|
$0.45 B |
0.000 M
|
USA
|
Telesis Bio
TBIO
|
$0.53 M |
0.000 M
|
USA
|
Vaxart
VXRT
|
$0.19 B |
-0.000 M
|
USA
|
Dynavax Technologies
DVAX
|
$1.63 B |
-0.000 M
|
USA
|
Altimmune
ALT
|
$0.49 B |
0.000 M
|
USA
|
Gritstone bio
GRTS
|
$3.80 M |
2.350 M
|
USA
|
Vir Biotechnology
VIR
|
$1.45 B |
0.000 M
|
USA
|
Iovance Biotherapeutics
IOVA
|
$1.83 B |
-0.000 M
|
USA
|
Market Cap | = | IMNN Stock Price | * | IMNN Shares Outstanding |
= | $0.89 | * | 14.50 M | |
= | $12.91 M |